Optimize IAS
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
    • Mains Master Notes
    • PYQ Mastery Program
  • Portal Login
    • Home
    • About Us
    • Courses
      • Prelims Test Series
        • LAQSHYA 2026 Prelims Mentorship
      • Mains Mentorship
        • Arjuna 2026 Mains Mentorship
      • Mains Master Notes
      • PYQ Mastery Program
    • Portal Login

    GENOMIC SURVEILLANCE CONSORTIUM

    • December 30, 2020
    • Posted by: OptimizeIAS Team
    • Category: DPN Topics
    No Comments

     

     

    GENOMIC SURVEILLANCE CONSORTIUM

    Subject: Science & technology

    Context: In the wake of a mutated variant of coronavirus detected in the UK, a genomic surveillance consortium has been formed for laboratory and epidemiological surveillance of circulating strains of the SARS-CoV-2 in India, the Centre said on Saturday.

    Concept:

    • Indian government has set up a genomic surveillance consortium – Indian SARS-CoV-2 Genomics Consortium (INSACOG) – under National Centre for Disease Control to detect the any circulating variants in the country.
    • The Central government said that more than 50 samples of returnees from the UK, are currently undergoing genome sequencing at the designated laboratories across the country.
    • The overall aim of the proposed consortium is to monitor the genomic variations in the SARS-CoV-2 on a regular basis through a multi-laboratory network.

    Pertinent objectives of the consortium:

    • To ascertain the current status of new variant of SARS-CoV-2 (SARS-CoV-2 VUI 202012/01) in the country
    • To establish a sentinel surveillance for early detection of genomic variants with public health implication
    • To determine the genomic variants in the unusual events/trends (super-spreader events, high mortality/morbidity trend areas etc.)

    India’s Action Plan

    • The country has ten regional genome sequencing laboratories, which will cater to their nearest states.
    • The states will send 5% of the positive samples to these labs for genome sequencing.
    • The data generated would then be analyzed by the respective centres and sent to the National Centre for Disease Control (NCDC), Delhi for collation and integration.
    • The data from the genome sequencing laboratories will be analyzed to study the linkages (if any) between the genomic variants and epidemiological trends.
    • This will help to understand super spreader events, outbreaks and strengthen public health interventions across the country to help in breaking the chains of transmission

    Genomic Sequencing

    • Genome sequencing refers to sequencing the entire genome of an organism.
    • It involves taking a “genetic fingerprint” of an organism and maps how the DNA or RNA inside it is ordered.
    • Looking at the genetic sequence of different cases, we can detect differences in each new infection and detect variations or mutations.
    GENOMIC SURVEILLANCE CONSORTIUM Science and tech
    Footer logo
    Copyright © 2015 MasterStudy Theme by Stylemix Themes
        Search